戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 inkgetin has been previously described as an anti-tumor agent.
2 ties suggest that 6Ckine may be an effective anti-tumor agent.
3 ce of the efficacy of thrombospondin-1 as an anti-tumor agent.
4 OA-inactivating group, making NMI a valuable anti-tumor agent.
5 y used in Traditional Chinese Medicine as an anti-tumor agent.
6 nts with HIV and is in clinical trials as an anti-tumor agent.
7 where antibodies have proven to be effective anti-tumor agents.
8 tion with conventional chemotherapy or other anti-tumor agents.
9 merization (ATRP) were explored as efficient anti-tumor agents.
10 elled the search for alternative metal-based anti-tumor agents.
11  may act similarly and could be developed as anti-tumor agents.
12 to DOX, lysosomal sequestration of the novel anti-tumor agent and P-glycoprotein (Pgp) substrate, di-
13 naldinium diiodide (DECA; dequalinium) is an anti-tumor agent and protein kinase C (PKC) inhibitor wh
14 l)benzothiazole 15, are under development as anti-tumor agents as well.
15 iscovery of JNJ-78394355: a highly efficient anti-tumor agent, as demonstrated by the in vivo studies
16 ant toxin that has potential as an effective anti-tumor agent by virtue of its enzymatic capacity to
17     The monomeric form is insensitive to the anti-tumor agent camptothecin and distributive during in
18         Herein, we investigate how the novel anti-tumor agent di-2-pyridylketone 4,4-dimethyl-3-thios
19 knowledge on the mechanisms of action of the anti-tumor agent DMXAA (currently in clinical trials) an
20 ate that triptonide holds promise as a novel anti-tumor agent for TNBC treatment.
21 analogs of BN have been designed as targeted anti-tumor agents for the treatment of various cancers t
22                            Several important anti-tumor agents form DNA interstrand crosslinks (ICLs)
23                                          The anti-tumor agents geldanamycin and radicicol bind specif
24 dertaken to evaluate the efficacy of a novel anti-tumor agent, GZ17-6.02, which is composed of curcum
25 7609, and S-28463, are potent anti-viral and anti-tumor agents in animal models.
26 ting apoptosis by both novel and established anti-tumor agents, including the anti-estrogens tamoxife
27        The potential of 4 as an orally dosed anti-tumor agent is confirmed using breast and prostate
28 hlorouridine, first reported in the 1950s as anti-tumor agent, is known as an effective mutagen, clas
29                              Moreover, novel anti-tumor agents of the di-2-pyridylketone class of thi
30 ~ SN-38 was ~ tenfold more efficacious as an anti-tumor agent than systemic SN-38.
31 s 11beta-dichloro, a repurposed DNA-damaging anti-tumor agent that induces apoptosis by exacerbating
32 axanes such as paclitaxel (Taxol) are potent anti-tumor agents that repress the dynamic instability o
33 have proven to be effective preclinically as anti-tumor agents, these promising results have yet to b
34 icant implications for improving delivery of anti-tumor agents to brain tumors.
35       The potential of this class of RKIs as anti-tumor agents warrants further advanced preclinical